Method and apparatus for atrial arrhythmia episode detection

US9486155B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9486155-B2
Application numberUS-201514695135-A
CountryUS
Kind codeB2
Filing dateApr 24, 2015
Priority dateFeb 18, 2015
Publication dateNov 8, 2016
Grant dateNov 8, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method and medical device for determining a P-wave of a cardiac signal that includes sensing the cardiac signal, determining a P-wave sensing window in response to the sensed cardiac signal, the P-wave sensing window having a first portion and a second portion, determining signal characteristics of the sensed cardiac signal within the first portion and within the second portion, comparing the determined signal characteristics, and determining the P-wave in response to the comparing.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of determining a P-wave of a cardiac signal in an implantable medical device, comprising: sensing the cardiac signal; identifying one or more R-waves within the cardiac signal; determining one or more P-wave sensing windows, wherein each of the P-wave sensing window is associated with one of the one or more identified R-waves; determining a characteristic P-wave sensing window based on the one or more determined P-wave sensing windows, the characteristic P-wave sensing window having a first portion and a second portion; determining a first derivative signal of the cardiac signal within the characteristic P-wave sensing window; determining a second derivative signal of the cardiac signal within the characteristic P-wave sensing window; analyzing the first derivative and the second derivative of the cardiac signal within the characteristic P-wave window to determine a first set of signal characteristics of the cardiac signal within the first portion of the characteristic P-wave sensing window and a second set of signal characteristics of the cardiac signal within the second portion of the characteristic P-wave sensing window, the signal characteristics including zero crossings of the first derivative signal and amplitudes of the second derivative signal corresponding to the determined zero crossings; and detecting the P-wave based on the first and the second set of signal characteristics. 2. The method of claim 1 , further comprising: determining a maximum amplitude of the determined amplitudes of the second derivative signal within the first portion; and comparing the amplitudes of the second derivative signal within the second portion to an amplitude threshold, wherein the amplitude threshold is determined based on the determined maximum amplitude of the second derivative signal within the first portion. 3. The method of claim 2 , wherein the amplitude threshold comprises a multiple of the determined maximum amplitude of the second derivative signal within the first portion. 4. The method of claim 2 , further comprising: determining a number of times the determined amplitudes of the second derivative signal within the second portion are greater than the amplitude threshold; and determining the P-wave based on the determined number of times. 5. The method of claim 4 , further comprising: determining an RR-interval associated with one of the one or more determined R-wave; determining a relative change associated with the RR-interval; comparing the determined RR-interval to an interval threshold and the determined relative change to a change threshold; and confirming the determined R-wave, wherein the P-wave sensing window is determined in response to the confirmed R-wave. 6. The method of claim 1 , further comprising: determining a maximum amplitude of the determined amplitudes of the second derivative signal within the first portion; determining a maximum amplitude threshold based on the determined maximum amplitude of the second derivative signal within the first portion; determining a minimum amplitude of the determined amplitudes of the second derivative signal within the first portion; determining a minimum amplitude threshold based on the determined minimum amplitude of the second derivative signal within the first portion; and comparing the amplitudes of the second derivative signal within the second portion to the maximum amplitude threshold and the minimum amplitude threshold. 7. The method of claim 6 , further comprising: determining a first number of times the determined amplitudes of the second derivative signal within the second portion are greater than the maximum amplitude threshold; determining a second number of times the determined amplitudes of the second derivative signal within the second portion are less than the minimum amplitude threshold; and determining the P-wave based on both the determined first number of times and the determined second number of times. 8. The method of claim 7 , further comprising determining the sensed cardiac signal within the first portion and within the second portion as a P-wave in response to either the first number of times being equal to one or the second number of times being equal to one. 9. The method of claim 1 , wherein the medical device comprises a subcutaneous device. 10. An implantable medical device for determining a P-wave in a cardiac signal, comprising: a plurality of electrodes configured to sense the cardiac signal; and a processor configured to identify one or more R-waves within the cardiac signal, determine one or more P-wave sensing windows, wherein each of the P-wave sensing windows is associated with one of the one or more identified R-waves, determine a characteristic P-wave sensing window based on the one or more determined P-wave sensing windows, the characteristic P-wave sensing window having a first portion and a second portion, determine a first derivative signal of the cardiac signal within the characteristic P-wave sensing window, determine a second derivative signal of the cardiac signal within the characteristic P-wave sensing window, analyze the first derivative and the second derivative of the cardiac signal within the characteristic P-wave window to determine a first set of signal characteristics of the cardiac signal within the first portion of the characteristic P-wave sensing window and a second set of signal characteristics of the cardiac signal within the second portion of the characteristic P-wave sensing window, the signal characteristics including zero crossings of the first derivative signal and amplitudes of the second derivative signal corresponding to the determined zero crossings, and detect the P-wave based on the first and the second set of signal characteristics. 11. The medical device of claim 10 , wherein the processor is further configured to determine a maximum amplitude of the determined amplitudes of the second derivative signal within the first portion, and compare the amplitudes of the second derivative signal within the first portion, and compare the amplitudes of the second derivative signal within the second portion to an amplitude threshold, wherein the amplitude threshold is determined based on the determined maximum amplitude of the second derivative signal within the first portion. 12. The medical device of claim 11 , wherein the amplitude threshold comprises a multiple of the maximum amplitude of the second derivative signal within the first portion. 13. The medical device of claim 11 , wherein the processor is configured to determine a number of times the determined amplitudes of the second derivative signal within the second portion are greater than the amplitude threshold, and determine the P-wave based on the determined number of times. 14. The medical device of claim 13 , wherein the processor is configured to determine an RR-interval associated with one of the one or more determined R-waves, determine a relative change associated with the RR-interval, compare the determined RR-interval to an interval threshold and the determined relative change to a change threshold, and confirming the determined R-wave, wherein the P-wave sensing window is determined in response to the confirmed R-wave. 15. The medical device of claim 10 , wherein the processor is configured to determine a maximum amplitude of the determined amplitudes of the second derivative signal within the first portion, determine a maximum amplitude threshold based on the determined maximum amplitude of the second derivative signal within the first portion, determine a min

Assignees

Inventors

Classifications

  • characterised by the timing or triggering of the shock · CPC title

  • controlled by gradient or slope of the heart potential · CPC title

  • for treating atrial fibrillation · CPC title

  • controlled by the heart rate variability · CPC title

  • A61N1/3624Primary

    occurring in the atrium, i.e. atrial tachycardia · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9486155B2 cover?
A method and medical device for determining a P-wave of a cardiac signal that includes sensing the cardiac signal, determining a P-wave sensing window in response to the sensed cardiac signal, the P-wave sensing window having a first portion and a second portion, determining signal characteristics of the sensed cardiac signal within the first portion and within the second portion, comparing the…
Who is the assignee on this patent?
Medtronic Inc
What technology area does this patent fall under?
Primary CPC classification A61N1/3624. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).